drugset / Trial / NCT02166398
A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan® Tablet 5/50 mg After a Single Oral Administration in Healthy Male Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
A randomized, open-label, single dose, two-way crossover clinical trial to compare the safety, pharmacokinetic profiles of UI15AML055MT and Amosartan® tablet 5/50 mg after a single oral administration in healthy male volunteers
Timeline
- Start
- 2014-06
- Primary completion
- 2014-10
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amlodipine | Other / unclassified | — | Oral |
| Comparator | Losartan | Other / unclassified | — | Oral |
| Subject | UI15AML055MT | Unknown | — | Oral |
Indications
No indication recorded.